We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Panel Shoots Down Oscient Request

Law360 (September 13, 2006, 12:00 AM EDT) -- A panel of the U.S. Food and Drug Administration said Tuesday that Oscient Pharmaceuticals Corp. had not proved its Factive drug is safe and effective enough to use for the treatment...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.